| Patent | Date |
|---|
Enhanced Therapeutic Usage Of A Purine Nucleoside Phosphorylase Or Nuceloside Hydrolase Prodrug
App 20220031817 - Parker; William B. ; et al. | 2022-02-03 |
Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography procedures
Grant 10,942,112 - Rowe , et al. March 9, 2 | 2021-03-09 |
Methods, Systems, Arrangements And Computer-accessible Medium For Providing Micro-optical Coherence Tomography Procedures
App 20190285539 - Rowe; Steven M. ; et al. | 2019-09-19 |
Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography procedures
Grant 10,241,028 - Rowe , et al. | 2019-03-26 |
Enhanced Therapeutic Usage Of A Purine Nucleoside Phosphorylase Or Nucleoside Hydrolase Prodrug
App 20180360929 - Parker; William B. ; et al. | 2018-12-20 |
Enhanced therapeutic usage of a purine nucleoside phosphorylase or nucleoside hydrolase prodrug
Grant 10,080,784 - Parker , et al. September 25, 2 | 2018-09-25 |
Purine Nucleoside Phosphorylase As Enzymatic Activator Of Nucleoside Prodrugs
App 20160022784 - EALICK; Steven E. ; et al. | 2016-01-28 |
Methods, Systems, Arrangements And Computer-accessible Medium For Providing Micro-optical Coherence Tomography Procedures
App 20150253240 - Rowe; Steven M. ; et al. | 2015-09-10 |
Purine Nucleoside Phosphorylase As Enzymatic Activator Of Nucleoside Prodrugs
App 20140199285 - Parker; William B. ; et al. | 2014-07-17 |
Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs
Grant 8,628,767 - Parker , et al. January 14, 2 | 2014-01-14 |
Enhanced Therapeutic Usage Of A Purine Nucleoside Phosphorylase Or Nucleoside Hydrolase
App 20130330315 - Parker; William B. ; et al. | 2013-12-12 |
Purine Nucleoside Phosphorylase As Enzymatic Activator Of Nucleoside Prodrugs
App 20110212073 - Parker; William B. ; et al. | 2011-09-01 |
Anti-tumoral Compositions Methods
App 20100151572 - Sorscher; Eric J. ; et al. | 2010-06-17 |
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
Grant 7,488,598 - Ealick , et al. February 10, 2 | 2009-02-10 |
Compounds promoting delivery of genes
Grant 7,473,527 - Sorscher January 6, 2 | 2009-01-06 |
Compounds promoting delivery of genes
App 20060233754 - Sorscher; Eric J. | 2006-10-19 |
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
Grant 7,037,718 - Ealick , et al. May 2, 2 | 2006-05-02 |
Recombinant bacterial cells for delivery of PNP to tumor cells
Grant 6,958,318 - Sorscher , et al. October 25, 2 | 2005-10-25 |
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
App 20050214901 - Ealick, Steven E. ; et al. | 2005-09-29 |
Gene delivery compounds
App 20040204375 - Sorscher, Eric J ; et al. | 2004-10-14 |
Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof
App 20030228576 - Ealick, Steven E. ; et al. | 2003-12-11 |
Human papillomavirus vectors for the episomal transduction of host cells and method of making same
Grant 6,605,281 - Broker , et al. August 12, 2 | 2003-08-12 |
Recombinant bacterial cells for delivery of PNP to tumor cells
App 20030134819 - Sorscher, Eric J. ; et al. | 2003-07-17 |
Recombinant bacterial cells for delivery of PNP to tumor cells
App 20030077268 - Sorscher, Eric J. ; et al. | 2003-04-24 |
Activating Cl- secretion
App 20020035138 - Maddry, Joseph A. ; et al. | 2002-03-21 |
Purine nucleoside phosphorylase gene therapy for human malignancy
Grant 6,017,896 - Sorscher , et al. January 25, 2 | 2000-01-25 |
Purine nucleoside phosphorylase gene therapy for human malignancy
Grant 5,552,311 - Sorscher , et al. September 3, 1 | 1996-09-03 |
| 